Fda Can make Alzheimer’s Drug Leqembi Broadly Accessible
[ad_1] The Meals and Drug Administration on Thursday gave comprehensive acceptance to the Alzheimer’s drug Leqembi, and Medicare said it would include a great deal of its large price tag, laying the foundation for widespread use of a treatment that can modestly slow cognitive decrease in the early phases of the illness but also carries…
Read More “Fda Can make Alzheimer’s Drug Leqembi Broadly Accessible” »